Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO

The ABC Trial is a study to test whether aspirin will keep breast cancer from recurring and reduce death from breast cancer

Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy

FORTE is a large, randomized trial of surveillance colonoscopy for participants with a first-time diagnosis of 1 or 2 small benign polyps

Positive results stemming from this phase II/III clinical trial indicate that the MEK-inhibitor trametinib would provide benefit as the new standard of care for treating women with recurrent low-grade serous carcinoma of the ovary/peritoneum

The addition of trastuzumab to chemoradiation and surgery did not improve disease-free survival rates for patients with HER2 overexpressing esophageal adenocarcinoma

Study provides significant evidence to consider paclitaxel and carboplatin the new standard of care for women with uterine carcinosarcoma

Major financial hardship common after cancer diagnosis, despite insurance

Combo with immunotherapy drug can be effective in patients who are not good candidates for chemo